Assignee
RESPONSE GENETICS INC
US·13 granted patents·4 pending applications·319 citations·filing 2001–2015
Top patents by PatentIndex Score
17 records- 0196US6602670B2Method of determining a chemotherapeutic regimen based on ERCC1 expressionRESPONSE GENETICS INC·Filed 2001·Granted Aug 5, 2003·103 cites·14 claims
- 0295US6582919B2Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival ratesRESPONSE GENETICS INC·Filed 2001·Granted Jun 24, 2003·123 cites·28 claims
- 0389US7132238B2Method of determining a chemotherapeutic regimen based on ERCC1 expressionRESPONSE GENETICS INC·Filed 2003·Granted Nov 7, 2006·23 cites·4 claims
- 0489US7049059B2Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressionRESPONSE GENETICS INC·Filed 2001·Granted May 23, 2006·25 cites·4 claims
- 0588US7732144B2Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressionRESPONSE GENETICS INC·Filed 2009·Granted Jun 8, 2010·4 cites·9 claims
- 0687US6518416B1Method of determining a chemotherapeutic regimen based on ERCC1 expressionRESPONSE GENETICS INC·Filed 2001·Granted Feb 11, 2003·15 cites·3 claims
- 0786US6573052B2Method of determining a chemotherapeutic regimen based on ERCCI expressionRESPONSE GENETICS INC·Filed 2001·Granted Jun 3, 2003·13 cites·5 claims
- 0879US7560543B2Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressionRESPONSE GENETICS INC·Filed 2006·Granted Jul 14, 2009·2 cites·4 claims
- 0975US6956111B2Method of determining dihydropyrimidine dehydrogenase gene expressionRESPONSE GENETICS INC·Filed 2001·Granted Oct 18, 2005·2 cites·6 claims
- 1074US6905821B2Method of determining Dihydropyrimidine dehydrogenase gene expressionRESPONSE GENETICS INC·Filed 2001·Granted Jun 14, 2005·2 cites·15 claims
- 1174US6686155B2Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expressionRESPONSE GENETICS INC·Filed 2001·Granted Feb 3, 2004·5 cites·13 claims
- 1269US8026062B2Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumorsRESPONSE GENETICS INC·Filed 2007·Granted Sep 27, 2011·0 cites·7 claims
- 1368US7138507B2Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expressionRESPONSE GENETICS INC·Filed 2003·Granted Nov 21, 2006·2 cites·3 claims
- 1459US2015184250A1Kras primers and probesRESPONSE GENETICS INC·Filed 2014·Application pending·0 cites
- 1558US2009092979A1Methods for isolating long fragment rna from fixed samplesRESPONSE GENETICS INC·Filed 2008·Application pending·0 cites
- 1649US2013029336A1KRAS Primers and ProbesRESPONSE GENETICS INC·Filed 2011·Application pending·0 cites
- 1747US2015161327A1Systems and methods for detecting biological featuresRESPONSE GENETICS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →